XML 19 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (AOCI)
Non-controlling Interest
Beginning balance at Dec. 31, 2012 $ 339,032 $ 42 $ (28,973) $ 3,549,533 $ (3,254,744) $ 40 $ 73,134
Beginning balance (in shares) at Dec. 31, 2012   42,155 (4,211)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options 2,377     2,377      
Equity-based compensation related to deferred stock units (DSUs) 377     377      
Equity-based compensation related to restricted stock (RS) 2,958     2,958      
Issuance of DSUs 359     359      
Issuance of DSUs (in shares)   60          
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (609) $ 0   (609)      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (in shares)   124          
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (11,735) $ 1   (11,736)      
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (in shares)   994          
Impact of redeemable noncontrolling interest accretion (1,088)     (1,088)      
Impact of sale of consolidated subsidiaries (42,315)           (42,315)
Impact of subsidiary equity transactions (5,799)     (5,410)     (389)
Repurchase of common stock (12,025)   $ (12,025)        
Repurchase of common stock (in shares)     (907)        
Net income (loss) 202,146       209,059   (6,913)
Ending balance at Dec. 31, 2013 473,678 $ 43 $ (40,998) 3,536,761 (3,045,685) 40 23,517
Ending balance (in shares) at Dec. 31, 2013   43,333 (5,118)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options 792     792      
Equity-based compensation related to deferred stock units (DSUs) 526     526      
Equity-based compensation related to restricted stock (RS) 21,818     21,818      
Issuance of DSUs 258     258      
Issuance of DSUs (in shares)   41          
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (1,822) $ 3   (1,825)      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (in shares)   2,777          
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (3,207)     (3,207)      
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (in shares)   254          
Impact of redeemable noncontrolling interest accretion (4,244)     (4,244)      
Impact of subsidiary equity transactions 1,586     2,551     (965)
Repurchase of common stock (12,809)   $ (12,809)        
Repurchase of common stock (in shares)     (774)        
Net income (loss) (27,820)       (23,556)   (4,264)
Ending balance at Dec. 31, 2014 448,756 $ 46 $ (53,807) 3,553,430 (3,069,241) 40 18,288
Ending balance (in shares) at Dec. 31, 2014   46,405 (5,892)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options 398     398      
Equity-based compensation related to deferred stock units (DSUs) 234     234      
Equity-based compensation related to restricted stock (RS) 23,120     23,120      
Issuance of DSUs 82     82      
Issuance of DSUs (in shares)   94          
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (4,170) $ 1   (4,171)      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (in shares)   253          
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (100)     (100)      
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (in shares)   11          
Impact of redeemable noncontrolling interest accretion (4,704)     (4,704)      
Impact of subsidiary equity transactions (4,803)     (4,441)     (362)
Repurchase of common stock (1,702)   $ (1,702)        
Repurchase of common stock (in shares)     (96)        
Net income (loss) (99,140)     0 (96,080)   (3,060)
Ending balance at Dec. 31, 2015 $ 357,971 $ 47 $ (55,509) $ 3,563,848 $ (3,165,321) $ 40 $ 14,866
Ending balance (in shares) at Dec. 31, 2015   46,763 (5,988)